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Background: To evaluate the impact of persistent smoking versus smoking cessation over one month prior to
surgery on early clinical outcomes in Chinese patients undergoing isolated coronary artery bypass grafting (CABG)
surgery in a retrospective study.
Methods: The peri-operative data of consecutive well-documented patients undergoing isolated CABG surgery
from January 2007 to December 2013 were investigated and retrospectively analyzed. All included patients were
divided into either a non-smoking group or a smoking group according to preoperative smoking records. Furthermore,
smokers were divided into either a former smoking subgroup (smokers with smoking cessation over 1 month before
surgery) or a current smoking subgroup (persistent smokers).
Results: A total of 3730 consecutive patients (3207 male patients and mean 63.6 ± 9.5 years) undergoing isolated CABG
surgery were analyzed. Persistent smokers had significantly higher incidence of postoperative pulmonary complications
as compared to non-smokers (7.8% vs. 4.5%, p = 0.0002). No significantly differences in both surgical mortality and major
postoperative morbidities between smokers with smoking cessation over 1 month before surgery and non-smokers were
found. In multiple logistic regression analysis, the risk of postoperative pulmonary complications in persistent smokers was
2.41 times than that in non-smokers, whereas the risk of postoperative pulmonary complications in smokers with smoking
cessation over 1 month before surgery was similar to non-smokers.
Conclusions: Persistent smokers had a higher incidence of pulmonary complications following CABG as compared to
non-smokers. Smoking cessation more than 1 month before surgery was expected to reduce early major morbidities
following CABG surgery.
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Smoking is a major risk factor for coronary heart dis-
ease. Previous study [1] reported smoking cessation has
brought about a reduction of incidence of coronary heart
disease of 12%. Coronary artery bypass grafting surgery
(CABG) is an important means of treatment of coronary
heart disease. Warner MA and colleagues [2] conducted
a blinded prospective study and showed that smokers
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unless otherwise stated.surgery had a higher incidence of postoperative pulmon-
ary complications as compared to smokers with smoking
cessation more than 2 months before CABG surgery.
With the progress in surgical techniques and postopera-
tive care, major morbidities following CABG were also
on the decline. Recently, it is reported that smoking
cessation more than 1 month before CABG procedure
evidently reduced pulmonary complications following
CABG surgery [3].
So far, China becomes the largest tobacco producer
and consumer in the world, with more than 300 million
smokers [4]. However, there are few reports about the
impact of smoking on clinical outcomes of Chinese patients
undergoing isolated CABG surgery. In this retrospectiveis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ing vs. smoking cessation over 1 month before surgery on
early postoperative clinical outcomes through reviewing




After approval by the ethics committee of Tongji hospital
affiliated to Tongji University, in accordance with the
Declaration of Helsinki, we reviewed the records of con-
secutive well-documented patients undergoing either emer-
gency or scheduled isolated CABG procedure with or
without cardiopulmonary bypass from January 2007 to
December 2013. Any patient with incomplete information
from preoperative smoking records was excluded from this
study. According to smoking records before CABG surgery,
all included patients were divided into either a smoking
group (smokers) or a non-smoking group (non-smokers).
Furthermore, the smoking group (smokers) was divided
into either a former smoking subgroup (smokers with
smoking cessation over 1 month before CABG surgery) or
a current smoking subgroup (persistent smokers). Data col-
lection was performed by trained staff (two people), and
they did not know the purpose of this study.
The details of the coronary artery lesions (SYNTAX
score [5]), in association with the preoperative characteris-
tics, was carefully evaluated for assignment to CABG with
(on-pump CABG) or without cardiopulmonary bypass
(off-pump CABG). In every patient complete anatomic
revascularization of all diseased vessels with a luminal
diameter greater than or equal to 1 mm was considered
necessary. If the operating surgeon judged a complete re-
vascularization feasible on the beating heart, off-pump
CABG was scheduled. In patients in whom the location or
the quality of the target vessels and the preoperative char-
acteristics (such as left ventricular end diastolic dimension,
left ventricular ejection fraction, etc.) was considered to
make off-pump revascularization technically too challen-
ging, on-pump CABG was scheduled. All the procedures
(either off-pump or on-pump CABG) were performed by
the same surgical team and there were no differences in
the rate of adoption of off-pump CABG between the dif-
ferent surgeons. In our center, off-pump CABG had been
performed routinely for >5 years before the launch of the
trial, and all of the operations were performed by 3 sur-
geons highly experienced in both off-pump and on-pump
surgery (each of the 3 participating surgeons performed at
least 50% of their CABG procedures as off-pump CABG).
Definition of surgical mortality and major postoperative
morbidities
Surgical mortality was defined as death that occurred
during the same hospitalization or within 30 days ofCABG surgery [6]. Major postoperative morbidities in-
cluded postoperative myocardial infarction, low cardiac
output syndrome (LCOS), new onset atrial fibrillation,
cardiac arrest or ventricular fibrillation, pulmonary com-
plications, renal failure, stroke, gastro-intestinal compli-
cations, incision infection, and multiple system organ
failure (MSOF). Postoperative myocardial infarction was
defined by either the appearance of new Q waves in 2 or
more contiguous leads on the electrocardiogram, or an
increase in the creatine kinase MB isoenzyme fraction of
more than 50U, in concert with an excess of 7% of the
total creatinine kinase level [7]. LCOS was considered
with those who met the following criteria before dis-
charge from first hospitalization in the intensive care
unit immediately after CABG surgery: 1. Need for ino-
tropic support with vasoactive drugs or mechanical cir-
culatory support with intra-aortic balloon pump to
maintain systolic blood pressure greater than 90 mmHg
after correction of all electrolytes and blood gas abnor-
malities while adjusting preload volume to its optimal
values; 2. Signs of impairment of body perfusion after
correction of all electrolytes and blood gas abnormalities
while adjusting preload volume to its optimal values [8].
New onset atrial fibrillation was considered as postoper-
ative intermittent or persistent new onset atrial fibrilla-
tion before discharge. Cardiac arrest or ventricular
fibrillation was defined as postoperative unexplained
heart arrest or ventricular fibrillation before discharge,
resulting in loss of cardiac ejection function, and requir-
ing cardiopulmonary resuscitation. Pulmonary complica-
tions included postoperative pneumonia which was
defined as a positive result in a sputum culture requiring
anti-infective treatment, or chest X-ray diagnosis of
pneumonia following CABG surgery [9] and postopera-
tive respiratory failure which was defined as the duration
of mechanical ventilation more than 48 h after surgery
or unplanned re-intubation within 30 days of surgery
[10] (although some previous reports defined postopera-
tive respiratory failure as requiring mechanical ventila-
tion > 72 h or re-intubation following surgery, this study
defined postoperative respiratory failure as requiring
mechanical ventilation > 48 h or re-intubation following
surgery in view of the majority of included patients
undergoing off-pump CABG). Renal dysfunction was de-
fined as serum creatinine greater than 2.5 mg/dl for
more than 7 days or requiring dialysis [11]. Stroke was
defined as a new focal or global dysfunction of cerebral
function lasting over 24 h. Gastro-intestinal complica-
tions included gastrointestinal bleeding, intestinal ob-
struction and other serious gastrointestinal dysfunction.
Incision infection meant the chest or leg wound infec-
tion requiring antibiotic therapy or operation [12].
MSOF (a severe dysfunction of at least two organ sys-
tems lasting for more than 24 h, as stated by the
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[13]) was recorded. In addition, duration of mechanical
ventilation and length of intensive care unit (ICU) stay
were also recorded.
Statistics analysis
Statistical analysis was performed using the SPSS 17.0
statistical software package. All p values <0.05 were con-
sidered to be statistically significant. Normal distribution
of measurement data was shown by mean ± standard de-
viation, and was compared between the groups by t-test.
Fisher’s exact test was employed to compare enumer-
ation data. In order to further confirm the reliability of
results, mortality and major postoperative morbidities
were further analyzed by multiple logistic regression
analysis. The covariate of regression analysis included age,
gender, body mass index, previous disease history (in-
cluded diabetes, hyperlipaemia, hypertension, chronic
obstructive pulmonary disease, myocardial infarction,
and peripheral vascular disease), left ventricular ejec-
tion fraction, application of the internal mammary




From January 2007 to December 2013, after obtaining
approval by the ethic committee, a total of 3856 con-
secutive patients undergoing isolated CABG were en-
tered into this study. One hundred and twenty-six
patients were excluded due to incomplete information
from preoperative smoking records, and finally 3730 pa-
tients (3207 male patients and mean 63.6 ± 9.5 years)
were retrospectively analyzed. According to preoperative
smoking records, 2186 patients (accounting for 58.6%)
who had more than 1 cigarette every day with continu-
ing at least 1 year were included into a smoking group,
and the other 1544 patients without a history of smoking
into a non-smoking group. And then, the smoking group
was divided either into a former smoking subgroup
(smokers with smoking cessation over 1 month before
CABG surgery, n = 614) or a current smoking group
(persistent smokers, n = 1572).
Baseline data of all included patients are shown in
Table 1. Comparing with the non-smoking group, the
smoking group was more likely to present with male
(98.6% vs. 68.1%, p < 0.0001), history of myocardial in-
farction (53.0% vs. 46.7%, p < 0.0001), chronic obstruct-
ive pulmonary disease (COPD) (14.0% vs. 6.1%, p <
0.0001), and high body mass index (BMI) (25.1 ± 3.1 kg/
m2 vs. 24.8 ± 3.2 kg/m2, p = 0.0041), but was less likely
to hypertension (50.5% vs. 58.1%, p < 0.0001) and hyper-
lipidemia (31.3% vs. 38.7%, p < 0.0001). Patients in thesmoking group was younger (62.2 ± 9.4 years vs. 65.7 ±
9.7 years, p < 0.0001) and had lower left ventricular ejec-
tion fraction (LVEF) (57.9 ± 9.9% vs. 59.7 ± 9.0%, p <
0.0001) as compared to the non-smoking group. And
comparing with the non-smoking group, the former
smoking subgroup was more likely to present with male
(98.0% vs. 68.1%, p < 0.0001), history of myocardial in-
farction (51.9% vs. 46.7%, p = 0.0029), COPD (15.8% vs.
6.1%, p < 0.0001), and high BMI (25.2 ± 3.0 kg/m2 vs.
24.8 ± 3.2 kg/m2, p = 0.0017), but was younger (60.7 ±
8.8 years vs. 65.7 ± 9.7 years, p < 0.0001) and had
lower LVEF (57.5 ± 9.7% vs. 59.7 ± 9.0%, p < 0.0001). In
addition, the current smoking subgroup was more likely
to present with male (98.9% vs. 68.1%, p < 0.0001), his-
tory of myocardial infarction (53.4% vs. 46.7%, p =
0.0002) and COPD (13.3% vs. 6.1%, p < 0.0001), but was
less likely to hypertension (48.3% vs. 58.1%, p < 0.0001)
and hyperlipidemia (30.0% vs. 38.7%, p < 0.0001) as com-
pared to the non-smoking group. Comparing with the
non-smoking group, the current smoking subgroup was
less likely to undergoing CABG with cardiopulmonary
bypass (17.6% vs. 27.1%, p < 0.0001) and had lower LVEF
(58.1 ± 9.8% vs. 59.7 ± 9.0%, p < 0.0001).
Early outcomes following CABG
The comparison of surgical mortality and major postop-
erative morbidities between the smoking group and
non-smoking group is shown in Table 2. A total of 92
patients were died, with a surgical mortality of 2.5%. The
smoking group had a low surgical mortality as compared
to the non-smoking group, but no statistical difference
was found (2.2% vs. 2.8%, p = 0.3348). The smoking
group had significantly higher incidence of postoperative
pulmonary complications (7.1% vs. 4.5%, p = 0.0010),
and significantly longer duration of mechanical ventila-
tion (9.8 ± 2.6 h vs. 9.4 ± 2.4 h, p < 0.0001) as compared
to the non-smoking group. There were no statistically
significant differences between the smoking group and
the non-smoking group in postoperative myocardial in-
farction, low cardiac output syndrome, new onset atrial
fibrillation, cardiac arrest or ventricular fibrillation, acute
kidney injury, stroke, gastro-intestinal complications, in-
cision infection, and multiple system organ failure.
The comparison of surgical mortality and major post-
operative morbidities between the current smoking sub-
group and non-smoking group is shown in Table 2.
There was no significant difference in surgical mortality
between the 2 groups (2.0% vs. 2.8%, p = 0.1579). Com-
paring with the non-smoking group, the current smok-
ing subgroup had significantly higher incidence of
postoperative pulmonary complications (7.8% vs. 4.5%,
p = 0.0002) and significantly longer duration of mechanical
ventilation (p < 0.001). There were no statistically signifi-
cant differences between the two groups in postoperative




Total Former smoking subgroup Current smoking subgroup
(n = 1544) (n = 2186) (n = 614) (n = 1572)
Age (years) 65.7 ± 9.7 62.2 ± 9.4* 60.7 ± 8.8* 65.3 ± 9.2
Male 1051 (68.1%) 2156 (98.6%)* 602 (98.0%)* 1554 (98.9%)*
BMI (kg/m2) 24.8 ± 3.2 25.1 ± 3.1* 25.2 ± 3.0* 24.9 ± 3.1
Familial history of CAD 1425(92.3%) 1994(91.2%) 556(90.6%) 1438(91.5%)
Diabetes mellitus 559(36.2%) 783(35.8%) 230(37.5%) 553(35.2%)
Hypertension 897(58.1%) 1103 (50.5%)* 344(56.0%) 759 (48.3%)*
Hyperlipemia 597(38.7%) 684 (31.3%)* 212(34.5%) 472 (30.0%)*
COPD 94 (6.1%) 306 (14.0%)* 97 (15.8%)* 209 (13.3%)*
History of MI 721(46.7%) 1158 (53.0%)* 319 (51.9%)* 839(53.4%)*
Prior CVA 240(15.5%) 348(15.9%) 108(17.6%) 240(15.3%)
Coronary artery lesion
Double-vessel 134(8.7%) 198 (9.0%) 54 (8.8%) 144(9.1%)
Triple-vessel 1408(91.2%) 1985(90.8%) 558(90.9%) 1427(90.8%)
Left main 378(24.5%) 529 (24.2%) 147 (23.9%) 382 (24.3%)
SYNTAX score
Low: ≤ 22 278 (18.0%) 306 (14.0%) 101 (16.4%) 200 (13.1%)
Intermediate: 23-32 793 (51.4%) 1194 (54.6%) 324 (52.8%) 870 (55.3%)
High: ≥33 473 (30.6%) 686 (31.4%) 189 (30.8%) 497 (31.6%)
LVEF (%) 59.7 ± 9.0 57.9 ± 9.9* 57.5 ± 9.7* 58.1 ± 9.8*
>50% 1275 (82.6%) 1631 (74.6%)* 463 (75.4%)* 1168 (74.3%)*
35-50% 178 (11.5%) 407(18.6%)* 99 (16.1%)* 308 (19.6%)*
<35% 91 (5.9%) 148 (6.8%)* 52(8.5%)* 96 (6.1%)
Emergence operation 123 (8.0%) 179 (8.2%) 49 (7.9%) 130 (8.3%)
On-pump CABG 418(27.1%) 439 (20.1%)* 163(26.5%) 276 (17.6%)*
CPB (min) 78.2 ± 31.4 79.6 ± 27.8 75.5 ± 24.8 80.1 ± 28.4
ACC (min) 57.2 ± 20.6 58.5 ± 19.5 57.4 ± 18.6 59.4 ± 20.6
Use of IMA 1518 (98.3%) 2144 (98.1%) 603 (98.2%) 1541 (98.0%)
Number of grafts 3.3 ± 0.5 3.3 ± 0.4 3.3 ± 0.6 3.3 ± 0.4
Fisher’s exact test was employed to compare enumeration data, and t-test to compare measurement data.
*p < 0.05 (as compared to Non-smoking group).
BMI, body mass index; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; CVA, cerebro-vascular accident; LVEF,
Left ventricular ejection fraction; CABG, coronary artery bypass grafting; On-pump CABG, CABG with cardiopulmonary bypass; CPB, cardiopulmonary bypass; ACC,
aortic cross clamp; IMA, internal mammary artery.
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onset atrial fibrillation, cardiac arrest or ventricular fibril-
lation, acute kidney injury, stroke, gastro-intestinal com-
plications, incision infection, and multiple system organ
failure.
The comparison of early outcomes following CABG
between the former smoking subgroup and the non-
smoking group is shown in Table 2. There were
no statistically significant differences between the 2
groups in surgical mortality, major postoperative
morbidities, and length of mechanical ventilation and
ICU stay.Logistic regression analysis
The impact of smoking on surgical mortality and major
postoperative morbidities after adjustment for potential
confounders (age, gender, BMI, diabetes, hyperlipaemia,
hypertension, COPD, recent myocardial infarction, per-
ipheral vascular disease, LVEF, application of internal
mammary artery, use of cardiopulmonary bypass, num-
ber of grafts) is shown in Table 3. In multivariate logistic
regression analysis, smoking had an independent influ-
ence on the development of postoperative pulmonary
complications (OR = 1.92, 95% CI 1.08-3.64). And, multi-
variate logistic regression analysis also showed that the
Table 2 Early clinical outcomes after CABG surgery
Non-smoking
group (n = 1544)
Smoking group
Total Former smoking subgroup Current smoking subgroup
(n = 2186) (n = 614) (n = 1572)
Surgical mortality 43(2.8%) 49(2.2%) 18(2.9%) 31(2.0%)
MI 16(1.7%) 24(1.1%) 8(1.3%) 16(1.0%)
LCOS 282(18.3%) 433(19.8%) 124(20.2%) 309(19.7%)
New onset AF 177(11.5%) 227(10.4%) 78(12.7%) 95(9.5%)
Ventricular fibrillation 29(1.9%) 46(2.1%) 15(2.4%) 31(2.0%)
Pulmonary complications 70 (4.5%) 156 (7.1%)* 34 (5.5%) 122 (7.8%)*
Mean ventilation time (h) 9.4 ± 2.4 9.8 ± 2.6* 9.5 ± 2.3 9.9 ± 2.7*
Renal failure 38(2.5%) 53(2.4%) 14(2.3%) 39(2.5%)
Stroke 31(2.0%) 20(0.9%) 5(0.8%) 15(1.0%)
GI complications 82(5.3 %) 120(5.5%) 19(3.1%) 101(6.4%)
Incision infection 21(1.4%) 33(1.5%) 9(1.5%) 24(1.5%)
MSOF 25(1.6%) 29(1.3%) 6(1.0%) 23(1.5%)
Mean length of ICU stay (h) 33.5 ± 6.9 34.2 ± 6.8 33.5 ± 6.1 34.5 ± 7.0
Mean was compared between the groups by t-test, and enumeration data by Fisher’s exact test.
*p < 0.05 (as compared to Non-smoking group).
MI, myocardial infarction; LCOS, low cardiac output syndrome; AF, atrial fibrillation; GI complications, gastro-intestinal complications; MSOF, multiple system organ
failure; ICU, intensive care unit.
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ent smokers was 2.41 times than that in non-smokers,
whereas the risk of postoperative pulmonary complica-
tions in smokers with smoking cessation over 1 month
before CABG was similar to non-smokers.
Discussion
Although the public gradually raised awareness of the
dangers of smoking and Chinese government attached
great importance to the tobacco control, the prevalence






Surgical mortality 1.0 1.10 (0.42-2.73)
MI 1.0 1.23 (0.48-3.12)
LCOS 1.0 1.13 (0.82-1.51)
New onset AF 1.0 1.07 (0.74-1.61)
Ventricular fibrillation 1.0 1.43 (0.65-3.14)
Pulmonary complications 1.0 1.92 (1.08-3.64)*
Renal failure 1.0 1.20 (0.54-2.63)
Stroke 1.0 0.92 (0.41-2.14)
GI complications 1.0 1.55 (0.45-4.75)
Incision infection 1.0 1.31 (0.44-4.78)
MSOF 1.0 1.14 (0.44-3.10)
*p < 0.05 (as compared to Non-smoking group).the current era [4]. The prevalence rate of smoking in
patients with coronary artery disease undergoing isolated
CABG surgery in this study touched 58.6%, with far
above 30% in the Western countries reports [14-16],
suggesting that the task of tobacco control was difficult,
and moreover, time was pressing. There were rare re-
ports about the impact of smoking on clinical outcomes
in Chinese patients undergoing isolated CABG. Based
on these, this study aimed to evaluate the impact of per-
sistent smoking vs. smoking cessation over 1 month be-
fore surgery on early postoperative clinical outcomes byFormer smoking subgroup Current smoking subgroup
OR (95% CI) OR (95% CI)
0.85 (0.31-2.42) 1.41 (0.42-3.91)
1.12 (0.43-2.89) 1.45 (0.63-3.49)
1.22 (0.82-1.84) 1.05 (0.85-1.38)
0.95 (0.62-1.62) 1.41 (0.77-2.21)
1.93 (0.78-4.82) 1.31 (0.58-2.95)
1.32 (0.61-3.16) 2.41 (1.21-4.64)*
1.05 (0.41-2.97) 1.38 (0.52-3.10)
0.41 (0.11-1.83) 0.29 (0.08-1.31)
0.51 (0.11-3.76) 1.79 (0.55-5.48)
2.11 (0.55-8.93) 1.17 (0.29-5.14)
0.62 (0.21-2.99) 1.51 (0.48-4.03)
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tory of smoking undergoing isolated CABG surgery.
The major finding of this study was that comparing
with non-smokers, persistent smokers were more likely
to suffer from postoperative pulmonary complications,
whereas smokers with smoking cessation over 1 month
before CABG surgery did not increase the incidence of
postoperative pulmonary complications. In this study,
univariate analyses showed that persistent smokers had a
higher incidence of postoperative pulmonary complica-
tions (7.8% vs. 4.5%, p = 0.0002) as compared to non-
smokers, whereas smokers with smoking cessation over
1 month before CABG surgery and non-smokers shared
a similar incidence of postoperative pulmonary compli-
cations (5.5% vs. 4.5%, p = 0.3183). Furthermore, mul-
tiple logistic regression analysis showed that the risk of
postoperative pulmonary complications in persistent
smokers was 2.41 times than that in non-smokers,
whereas the risk of postoperative pulmonary complica-
tions in those smokers with smoking cessation over
1 month before CABG was similar to non-smokers.
Reason of this difference may be that smoking caused
obstructive ventilation function disturbance and aggra-
vated respiratory disease, contributing to postoperative
pulmonary complications, whereas smoking cessation
over 1 month may gradually improve ciliary function
and macrophage phagocytic function, and steadily de-
creased the sputum, resulting in the reduction of post-
operative pulmonary complications in a few weeks
[17,18]. This result was consistent with previous stud-
ies [2,3,14,15,17,18]. In addition, smokers with smok-
ing cessation over 1 month before CABG surgery and
non-smokers shared a similar incidence of major post-
operative morbidities, suggesting that smoking cessation
more than 1 month before CABG surgery was expected to
reduce early major morbidities after CABG surgery and to
accelerate recovery.
This study showed smokers were less likely to hyper-
tension and hyperlipidemia as compared to non-smokers.
Reason of this difference may be the age, regarding that
smokers suffered with coronary atherosclerosis received
treatment in their youth, and thus were less likely to suf-
fering from senile diseases, such as hypertension, hyper-
lipidemia [19]. In this study, smokers were more likely to
history of myocardial infarction and had lower left ven-
tricular ejection fraction as compared to non-smokers.
Higher incidence of myocardial infarction, in association
with reduction of cardiac function, may lead to more ser-
ious condition, hence may unfavourable for postoperative
recovery. This study also showed that there was no signifi-
cant difference in surgical mortality between smokers and
non-smokers, which was consistent with Al-Sarraf N’s
study [20]. Smokers were younger and had lower inci-
dence of hypertension and hyperlipidemia, but had higherincidence of chronic disease obstructive pulmonary dis-
ease and history of myocardial infarction with poor cardio-
pulmonary function, and then had the similar surgical
mortality to non-smokers [3,14].
So far, few studies have assessed the relationship be-
tween persistent smoking vs. smoking cessation before
surgery and early clinical outcomes of Chinese patients
undergoing isolated CABG surgery. This study showed
that persistent smoking increased postoperative pulmon-
ary complications, which not only prolonged rehabilita-
tion, but also may cause other morbidities, consequently
increasing the financial burden. Smoking cessation over
1 month before CABG surgery was expected to reduce
early major morbidities after CABG surgery.
There are some limitations of this study. This study
was only a retrospective observational trial, which may
influence the generalizability. Secondly, relatively low
postoperative morbidities and mortality in this study
may cause false negative result, which remained to be re-
solved by expanding the sample size. Finally, this study
focused on the early clinical outcomes, and further
follow-up study involving larger sample size were needed
to determine the effect of smoking on long-term clinical
outcomes after CABG surgery.
Conclusions
Persistent smokers had a higher incidence of pulmonary
complications following CABG as compared to non-
smokers. Smoking cessation more than 1 month before
CABG surgery was expected to reduce early major
morbidities after CABG surgery.
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